
The pharmaceutical group Leo Pharma, which is investing billions of Danish kroner in a new growth strategy, is now dividing its operations into five international regions, according to Danish business daily Børsen.
Ceo of the company, Gitte Aabo, says that the aim is - as a part of the international strategy - to cover significant parts of the globe through the company’s own sales organizations.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app